埃马纽埃尔·利涅尔 - 制药者
Emmanuel Ligner - The Medicine Maker
生物技术与制药领域的最新动态
Emmanuel Ligner - The Medicine Maker
Cellular Origines partners with Johnson & Johnson - European Biotechnology Magazine
Illumina picks up proteomics developer SomaLogic from Standard BioTools for $425M - Fierce Biotech
Illumina to Acquire SomaLogic from Standard BioTools - GEN - Genetic Engineering and Biotechnology News
Illumina to buy SomaLogic in deal worth up to $425M - BioPharma Dive
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy - PR Newswire
Waters Highlights HPLC System Software Upgrades at HPLC 2025 - LCGC International
Enhancing protein purification efficiency with advanced filtration solutions - BioTechniques
Bionova Scientific Expands Capacity and Joins Advanced Therapies Market - GEN - Genetic Engineering and Biotechnology News
Cytiva and Argonaut Collaborate to Expand Reagent Lyophilization Manufacturing in EU and US - BioSpace
Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics - Forbes
Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity - PR Newswire
Cytiva completes projects in Asia, US & Europe with $1.6 B strategic investment - BioSpectrum Asia
Cytiva outlines $1.6bn facility investment plans through 2028 - BioProcess International
Cytiva Completes $1.6 billion in Strategic Investments to Further Enhance Global Supply Chain - GEN - Genetic Engineering and Biotechnology News
Video: Two Illumina scientists share their “why” - Illumina
Accelerate Your Gene Therapy Journey with Services Tailored to You - BioProcess International
UCL Cytiva Centre of Excellence (COE) - University College London
Strategic planning in ADC development: insights from Lonza - Drug Target Review
Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy in China - Endpoints News